Cervical Adenocarcinoma — Trials

Cervical Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

285 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 91
Recruiting: 41
Ph III recruiting: 9
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00389974	Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery	completed	Phase 2	19	National Cancer Institute (NCI)NIH	1	Feb 16, 2015	clinicaltrials
NCT00025467	Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer	completed	Phase 2	60	National Cancer Institute (NCI)NIH	1	Jan 24, 2013	clinicaltrials